论文部分内容阅读
目的观察DSG-Ⅰ型电脑肝病治疗仪治疗慢性乙型肝炎和肝炎肝硬化的疗效。方法129例慢性乙型病毒性肝炎和肝炎肝硬化患者随机分为两组,对照组给予常规药物治疗,治疗组在常规治疗的基础上加用DSGⅠ型(生物信息)电脑肝病治疗仪照射肝区。观察治疗前、后患者临床症状、肝功能、肝纤维化指标及外周血T细胞亚群、白细胞介素(IL)-2、IL-6、IL-8水平的变化。结果治疗后治疗组患者血清丙氨酸氨基转移酶、总胆红素、肝纤维化指标显著降低,白蛋白、A/G和T4/T8比值显著升高,而治疗前增高的血清IL-2、IL-6、IL-8,随病情恢复而下降,同时失眠、肝区不适症状明显好转。结论DSGⅠ型电脑肝病治疗仪治疗能改善慢性乙型病毒性肝炎和肝炎肝硬化患者的临床症状,恢复肝功能,降低肝纤维化指标,且能激活人体的免疫系统,促进肝病康复。
Objective To observe the curative effect of DSG-Ⅰ computerized liver disease treatment instrument on chronic hepatitis B and hepatitis cirrhosis. Methods 129 patients with chronic hepatitis B and hepatitis cirrhosis were randomly divided into two groups. The control group was given conventional drug treatment. The treatment group was treated with DSG type Ⅰ (bioinformatics) computerized liver disease treatment instrument on the basis of routine treatment. . The changes of clinical symptoms, liver function, liver fibrosis indexes and T lymphocyte subsets, interleukin (IL) -2, IL-6 and IL-8 levels in peripheral blood were observed before and after treatment. Results Serum levels of alanine aminotransferase, total bilirubin and hepatic fibrosis were significantly decreased, albumin, A / G and T4 / T8 ratios were significantly increased in the treatment group after treatment, while serum IL-2 , IL-6, IL-8, decreased with the recovery of the condition, while insomnia, liver symptoms improved significantly. Conclusion DSGⅠhepatitis treatment instrument can improve the clinical symptoms, liver function and liver fibrosis in patients with chronic hepatitis B and hepatitis cirrhosis, and can activate the body’s immune system and promote the recovery of liver disease.